Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population

Clinical Pharmacology and Therapeutics
Soo-Chin LeeBoon-Cher Goh

Abstract

Chinese and Malay subjects have been reported to require less maintenance warfarin than Indians that could not be accounted for by cytochrome P450 (CYP) 2C9 variants. Vitamin K epoxide reductase complex 1 (VKORC1) is the target enzyme of warfarin, and VKORC1 intronic variants and haplotypes have recently been shown to influence VKORC1 activity and warfarin requirements. We sequenced the coding regions of CYP2C9 and VKORC1 and inferred VKORC1 haplotype from 10 intronic variants in 147 Chinese, 85 Malay, and 43 Indian patients receiving maintenance warfarin. The mean weight-normalized warfarin dose was lower for Chinese and Malays than for Indians (0.058 +/- 0.025 mg/kg, 0.059 +/- 0.023 mg/kg, and 0.089 +/- 0.036 mg/kg, respectively; P < .001 for comparisons between Chinese and Malays with Indians). CYP2C9*2 and VKORC1 coding region variants were rare (<2%), whereas CYP2C9*3 associated with lower warfarin requirements was less common in Chinese and Malays (7% and 9%, respectively) than in Indians (18%) and could not account for their lower warfarin requirements. VKORC1 H1 and H7/H8/H9 haplotypes were associated with lower and higher warfarin requirements, respectively (0.050 +/- 0.019 mg/kg and 0.092 +/- 0.057 mg/kg, respectively...Continue Reading

Citations

Oct 19, 2006·Human Genetics·Mia WadeliusPanos Deloukas
Aug 3, 2012·Journal of Human Genetics·Anil PathareRajagopal Krishnamoorthy
Mar 2, 2011·The Pharmacogenomics Journal·A PavaniV K Kutala
Mar 7, 2008·The New England Journal of Medicine·Ute I SchwarzC Michael Stein
Feb 13, 2010·Pharmacogenetics and Genomics·Derek Van BoovenRuss B Altman
Jun 7, 2011·BMC Medical Genetics·Ivet M SuriapranataSusan Sw Tai
Oct 12, 2010·Drug Metabolism and Pharmacokinetics·Alisara SangviroonJule Namchaisiri
Nov 21, 2008·Pharmacogenomics·Jamila A PeriniGuilherme Suarez-Kurtz
Sep 11, 2008·Pharmacogenomics·Hedi SchellemanStephen E Kimmel
Oct 22, 2009·Pharmacogenomics·Ming Ta Michael LeeYuan-Tsong Chen
May 28, 2010·Pharmacogenomics·Stuart A ScottRobert J Desnick
Apr 4, 2008·Pharmacogenomics·Judith Maria LeitnerBernd Jilma
May 28, 2014·The Pharmacogenomics Journal·L R BrunhamY Y Teo
Sep 16, 2009·Pharmacogenetics and Genomics·Andrea L JorgensenMunir Pirmohamed
Mar 13, 2013·Current Opinion in Cardiology·Mohamed H A Shahin, Julie A Johnson
Nov 10, 2015·Expert Opinion on Drug Metabolism & Toxicology·Nicholas Li-Xun SynBoon-Cher Goh
Jul 15, 2015·Genetic Testing and Molecular Biomarkers·Yi LiJianqiang Ding
Nov 6, 2008·International Journal of Laboratory Hematology·T CasimireK S Charles
Nov 13, 2007·British Journal of Clinical Pharmacology·Suman LalBalram Chowbay
Oct 9, 2015·Research in Cardiovascular Medicine·Avisa TabibBehzad Poopak
Jan 15, 2010·Clinical Pharmacology and Therapeutics·L H CavallariJ A Johnson
Aug 30, 2008·Clinical Pharmacology and Therapeutics·J A PeriniG Suarez-Kurtz
Jun 10, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ross A SooRichie Soong
Sep 12, 2009·Drug Metabolism and Pharmacokinetics·Edwin SandanarajBalram Chowbay
Jun 23, 2009·Trends in Pharmacological Sciences·Daniel E Jonas, Howard L McLeod

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.